Blum Center Program: Current Approaches for Colorectal Cancer Screening
In this presentation from February 3, 2022, Dr. Daniel Chung discusses specific risks for colon cancer that can help guide your choice of screening test.
Contact Information
To make an appointment or if you have any questions, please contact our access team at 617-724-4000, Option 1.
With the alarming rise in colorectal cancer in patients under 50 years old, the Mass General Cancer Center established the Center for Young Adult Colorectal Cancer, a comprehensive, multidisciplinary program to address the unique needs of young and mid-life adults with colorectal cancer.
The Center for Young Adult Colorectal Cancer at the Mass General Cancer Center was created to address the vast unmet needs of colorectal cancer patients under the age of 50 and to provide specialized and personalized care for these patients. With this program, we hope to move the needle for these patients focusing on interception and intervention to advances therapeutic approaches for patients. Often these adults may feel as though they do not fit the description of an adolescent young adult, nor with the average age of the elderly colorectal cancer patient.
At the Mass General Cancer Center, patients will have the opportunity to see a comprehensive care team from medical oncology, radiation oncology, and surgery at their first visit and in a single multidisciplinary appointment. They can expect to have their ongoing care from a team of experts who specialize in their unique population and who have a vested interest in colorectal cancer research in young and mid-life adults. This team includes medical oncologists, radiation oncologists, and gastrointestinal (GI) surgeons as well as Advanced Practice Providers (APPs), clinical and research nurses, gastroenterologists, radiologists, and genetic counselors.
Young adult patients with metastatic colorectal liver cancer (cancer that has spread from the colon to the liver) have access to Mass General's Hepatic Artery Infusion Pump Program, a highly specialized, multidisciplinary collaboration that uses hepatic artery pumps (also known as liver chemotherapy pumps) to treat primary and metastatic tumors of the liver.
Led by director Aparna Parikh, MD, the Young Adult Colorectal Cancer Center offers each patient a multidisciplinary team of experienced colorectal cancer specialists.
Our Center for Young Adult Colorectal Cancer also provides patients with many services tailored to young and mid-life adult patients, including but not limited to:
What is Early-Onset or Young-Onset Colorectal Cancer?
Colorectal cancer patients diagnosed before the age of 50 are considered early-onset or young-onset patients.
What are the current colorectal cancer screening guidelines?
The U.S. Preventive Services Task Force (USPSTF) recently revised colorectal cancer screening guidelines to start earlier at age 45 instead of 50 for people at average risk given the rise of colorectal cancer in younger patients.
Why has there been a rise in colorectal cancer in adults under 50 years old?
The reasons for the rise in colorectal cancer in adults under 50 years old is under active investigation and is multifactorial including a combination of genetics and non-genetic external factors such as diet, exercise and environmental factors.
How is the Center for Young Adult Colorectal Cancer at the Mass General Cancer Center focused on colorectal cancer in patients under 50 years old?
Our multidisciplinary team of experts specialize in colorectal cancer in patients under 50 years old. As part of the Tucker Gosnell Center for Gastrointestinal Cancers at Mass General Cancer Center, our specialists provide in-depth expertise in diagnosis, treatment, and survivorship.
What does a first appointment in the program look like/what can I expect during my first appointment?
At the first appointment, when appropriate, patients will meet with a team from medical and radiation oncology, and surgery --- all in one exam room, all during one, single appointment. This truly multidisciplinary appointment structure provides patients with the convenience of talking with their care team as a group, and the comfort of knowing their care team is in sync with each other in determining the patient’s best course for treatment.
What support services does the Cancer Center offer?
We offer a variety of educational and support resources to help patients and their families throughout their cancer experience. We understand that early-onset or young-onset colorectal cancer patients may have concerns specific to their stage in life, so we offer support services tailored to their needs, including services that address fertility, parenting, sexual health, diet and nutrition, exercise, mental health, genetic counseling, and more.
I’m a parent. Do you have resources to help me during this time?
Yes. Our Parenting At a Challenging Time (PACT) program has clinicians who are available to consult with young adult colorectal cancer patients who are parents.
The Center for Young Adult Colorectal Cancer has a robust research portfolio tailored for this unique population. Some examples include:
Find clinical trials for colorectal cancer
Principal Investigator: Kelsey Lau-Min, MD, MSCE
Description: PATHWAYS is a randomized controlled trial assessing the efficacy of an informational and supportive care intervention for patients with locally advanced rectal cancer who are receiving chemotherapy and/or radiation before possible surgery. This program consists of a comprehensive educational guide paired with four coaching sessions to help participants build skills for managing and coping with any challenges that may arise during their treatment.
Alexa Morell
Diagnosed with young-onset colorectal cancer at 29 years old, Alexa shares her journey navigating motherhood, cancer treatment, and advocating for others.
Lauren Hindman
As a patient in our Center for Young Adult Colorectal Cancer, Lauren has formed a close relationship with her surgeon, Motaz Qadan, MD, PhD, and together they have navigated the impact this disease has had on Lauren.
Colorectal cancer is a disease in which cancer (malignant) cells grow and multiply in the tissues of the colon or rectum.
We help identify families that may have a hereditary colon cancer syndrome.
Provides expert and lifelong care for individuals and families affected by Lynch syndrome.
Learn more about out treatment program for patients with colon cancer.
Mass General's Colorectal Surgery Program offers expert surgical care.
Learn about the GI program in the Department of Radiation Oncology.
We offer a variety of education and support resources to help you and your family.
We offer a wide range of integrative therapies, workshops and support groups.
Learn about colorectal cancer and meet Aparna Parikh, MD, medical director of the Center for Young Adult Colorectal Cancer at Mass General Cancer Center, who details why colorectal cancer is being increasingly diagnosed in younger patients around the world.
What are complex gastrointestinal, or GI, cancers? Learn more about the multiple symptoms of gastrointestinal cancer, its diagnosis, and the treatment options available at Mass General Cancer Center.
In this presentation from February 3, 2022, Dr. Daniel Chung discusses specific risks for colon cancer that can help guide your choice of screening test.
Chandrika Kurpad, MS, LCGC, discusses colon cancer-causing genes and what you can do if colon cancer runs in your family.
Ted Hong, MD, radiation oncologist and avid hockey player explains how the Mass General Cancer Center’s multidisciplinary approach to developing care plans for patients is so beneficial to the patient. He also talks about his love for the game of hockey and the beauty of teamwork.
Oncology Social Work is offering an 11-week Colorectal Cancer Support Group open to all colorectal patients at the Mass General Cancer Center ages 45 and under. The group is designed to provide a space for patients to connect and share their experience of navigating treatment and life with cancer. The Colorectal Cancer Support Group will meet every other week on Wednesdays from 5:00-6:30pm via Zoom, beginning January 29th.
For more information or to register, please contact Stephanie Petruzzi, LICSW at stephanie.petruzzi@mgh.harvard.edu or 617-726-1128.
Mass General has the only proton therapy site in all of New England, with two proton therapy centers.
Our support programs can help patients and their families cope with the challenges of a cancer diagnosis.
View inspiring cancer survivor stories from Mass General Cancer Center’s community of patients, families, and staff.
Mass General provides its outcomes and performance data for colorectal surgery including rates of recovery and complications.
In this presentation from February 3, 2022, Dr. Daniel Chung discusses specific risks for colon cancer that can help guide your choice of screening test.
Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. A portion of these colon cancers are due to genetic predisposition genes. The Blum Center shares more in a recent presentation.
Andrew Chan, MD, MPH is co-leading the global team known as PROSPECT, which received a grant of up to $25m over five years, to study early-onset colorectal cancer from Cancer Grand Challenges after an international competition.
Bench-to-bedside research led from preclinical experiments to a durable response among patients with a difficult-to-treat form of colorectal cancer.
A new study reports a 50 to 60 percent lower risk of colorectal cancer (CRC) among women who started endoscopy screening at age 45 compared to those who had not undergone screening at all.
As a patient in our Center for Young Adult Colorectal Cancer, Lauren has formed a close relationship with her surgeon, Motaz Qadan, MD, PhD, and together they have navigated the impact this disease has had on Lauren.
In this presentation from February 3, 2022, Dr. Daniel Chung discusses specific risks for colon cancer that can help guide your choice of screening test.
Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. A portion of these colon cancers are due to genetic predisposition genes. The Blum Center shares more in a recent presentation.
Andrew Chan, MD, MPH is co-leading the global team known as PROSPECT, which received a grant of up to $25m over five years, to study early-onset colorectal cancer from Cancer Grand Challenges after an international competition.
Bench-to-bedside research led from preclinical experiments to a durable response among patients with a difficult-to-treat form of colorectal cancer.
The Center for Young Adult Colorectal Cancer at Mass General Cancer Center was created to address the vast unmet needs of colorectal cancer patients under the age of 50 and to provide specialized and personalized care for these patients.